Dbx Strip
Filler, Bone Void, Osteoinduction (W/O Human Growth Factor). 510(k) K062205, from Musculoskeletal Transplant Foundation (Edison, NJ). Product code MBP, class 2.
As of Nov 17, 2026, K062205 is an FDA 510(k) held by Musculoskeletal Transplant Foundation, substantially equivalent on Feb 5, 2007 after 188 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Feb 5, 2007
- Review time: 188 days
- Recalls: 0
- Cited as a predicate by: 4 devices
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFDBX® Strip is indicated as a bone void filler for treatment of surgically created osseous voids or gaps that are not intrinsic to the stability of the bony structure. It can be used in the pelvis, extremities, and the posterolateral spine for posterolateral fusion. DBX® Strip, when used for posterolateral spine fusion, may be used with autograft. DBX® Strip is for single patient use only.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Dbx StripK042829 · Musculoskeletal Transplant Foundation · Jan 13, 2006
Cited as a Predicate
4 later 510(k) summaries name this device as a predicate- BellaFuseK151271 · Hans Biomed Corp. · Mar 11, 2016
- Mtf New Bone Void FillerK121313 · Musculoskeletal Transplant Foundation · Jan 11, 2013
- Mtf New Bone Voild FillerK113167 · Musculoskeletal Transplant Foundation · Jan 24, 2012
- Mtf New Bone Void FillerK110003 · Musculoskeletal Transplant Foundation · Oct 13, 2011
Other MBP Clearances
The newest 510(k)s for the same product code; see every MBP device- PliaFX FloK242799 · Lifenet Health · Nov 21, 2024
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 1, 2006
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3045
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files